ReviewHeliyon2023
The prenatal diagnostic indicators of placenta accreta spectrum disorders.
Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The diagnostic value of multiple schemes of MRI standard features combined with risk factors and ultrasound for Placenta accreta spectrum.BMC pregnancy and childbirth · 2026Article
- Placenta Accreta Spectrum: Diagnostic Challenges and Management Strategies.Diagnostics (Basel, Switzerland) · 2026Review
- Placenta Accreta Spectrum in a Patient Without Prior Cesarean Delivery: A Case of Posterior Placenta Previa.Cureus · 2026Article
- Article
- Prediction of Placenta Accreta Spectrum Disorders in Complete Placenta Previa Complicated with Prior Cesarean.International journal of women's health · 2026Article
- Preoperative cystoscopy as a risk stratification tool for massive hemorrhage in placenta accreta spectrum.BMC pregnancy and childbirth · 2025Article
- Machine learning applications in placenta accreta spectrum disorders.European journal of obstetrics & gynecology and reproductive biology: X · 2025Review
- Advances in Prenatal Diagnosis of Placenta Accreta Spectrum.Medicina (Kaunas, Lithuania) · 2025Review
- Additional Role of Magnetic Resonance Imaging to Ultrasound in Assessing Placenta Accreta Spectrum Disorders: A Retrospective Cross-sectional Study from Vietnam.Oman medical journal · 2024Article
- Diagnostic Role of Cell-Free miRNAs in Identifying Placenta Accreta Spectrum during First-Trimester Screening.International journal of molecular sciences · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Placenta accreta spectrum (PAS) disorders refers to a heterogeneous group of anomalies distinguished by abnormal adhesion or invasion of chorionic villi through the myometrium and uterine serosa. PAS frequently results in life-threatening complications, including postpartum hemorrhage and hysterotomy. The incidence of PAS has increased recently as a result of rising cesarean section rates. Consequently, prenatal screening for PAS is essential. Despite the need to increase specificity, ultrasound is still considered a primary adjunct. Given the dangers and adverse effects of PAS, it is necessary to identify pertinent markers and validate indicators to improve prenatal diagnosis. This article summarizes the predictors regarding biomarkers, ultrasound indicators, and magnetic resonance imaging (MRI) features. In addition, we discuss the effectiveness of joint diagnosis and the most recent research on PAS. In particular, we focus on (a) posterior placental implantation and (b) accreta after in vitro fertilization-embryo transfer, both of which have low diagnostic rates. At last, we graphically display the prenatal diagnostic indicators and each diagnostic performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.